Latest National Institute for Health and Clinical Excellence Stories
PATIENTS with advanced kidney cancer will be denied four treatments on the NHS under new guidelines published today.
By JANE KIRBY Broadcaster James Whale accused a health watchdog today of being "barbaric" in denying kidney cancer patients access to four drugs.
GlaxoSmithKline plans to renegotiate with the UK's Department of Health as part of its attempt to reverse the National Health Service's decision regarding the company's cancer drug Tyverb, reported the Financial Times.
By Barry Nelson PATIENTS with advanced kidney cancer were dealt a devastating blow last night when spending watchdogs effectively banned four life- giving drugs on the NHS.
Lord Darzi's recent plan for the NHS may only have concerned England, but his ideas for speeding up the drug appraisals process could have implications for the All Wales Medicines Strategy Group.
The medical advisory panel to the UK National Health Service has recommended that GlaxoSmithKline's Tyverb should not be used on the NHS to treat advanced metastatic breast cancer on the grounds that it is not effective enough to justify its cost.
The National Institute of Health and Clinical Excellence has advised against the use of GlaxoSmithKline's oral cancer drug Tyverb in the UK's National Health Service, reported the Financial Times.
THOSE people faced with the threat of losing their sight will rejoice that a treatment is now available on the NHS in Yorkshire which might prevent this terrible prospect.
In a nutshell Government drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has approved a controversial weight-loss drug for use on the NHS.
By Lyndsay Moss Health Correspondent DENYING patients free treatment because they choose to pay for drugs not available on the NHS is inhumane, the leader of Scotland's doctors says.
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.